Open Access

CT‑based radiomics analysis of consolidation characteristics in differentiating pulmonary disease of non‑tuberculous mycobacterium from pulmonary tuberculosis

  • Authors:
    • Qinghu Yan
    • Wenlong Zhao
    • Haili Kong
    • Jingyu Chi
    • Zhengjun Dai
    • Dexin Yu
    • Jia Cui
  • View Affiliations

  • Published online on: January 24, 2024     https://doi.org/10.3892/etm.2024.12400
  • Article Number: 112
  • Copyright: © Yan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Global incidence rate of non‑tuberculous mycobacteria (NTM) pulmonary disease has been increasing rapidly. In some countries and regions, its incidence rate is higher than that of tuberculosis. It is easily confused with tuberculosis. The topic of this study is to identify two diseases using CT radioomics. The aim in the present study was to investigate the value of CT‑based radiomics to analyze consolidation features in differentiation of non‑tuberculous mycobacteria (NTM) from pulmonary tuberculosis (TB). A total of 156 patients (75 with NTM pulmonary disease and 81 with TB) exhibiting consolidation characteristics in Shandong Public Health Clinical Center were retrospectively analyzed. Subsequently, 305 regions of interest of CT consolidation were outlined. Using a random number generated via a computer, 70 and 30% of consolidations were allocated to the training and the validation cohort, respectively. By means of variance threshold, when investigating the effective radiomics features, SelectKBest and the least absolute shrinkage and selection operator regression method were employed for feature selection and combined to calculate the radiomics score. K‑nearest neighbor (KNN), support vector machine (SVM) and logistic regression (LR) were used to analyze effective radiomics features. A total of 18 patients with NTM pulmonary disease and 18 with TB possessing consolidation characteristics in Jinan Infectious Disease Hospital were collected for external validation of the model. A total of three methods was used in the selection of 52 optimal features. For KNN, the area under the curve (AUC; sensitivity, specificity) for the training and validation cohorts were 0.98 (0.93, 0.94) and 0.90 (0.88, 083), respectively; for SVM, AUC was 0.99 (0.96, 0.96) and 0.92 (0.86, 0.85) and for LR, AUC was 0.99 (0.97, 0.97) and 0.89 (0.88, 0.85). In the external validation cohort, AUC values of models were all >0.84 and LR classifier exhibited the most significant precision, recall and F1 score (0.87, 0.94 and 0.88, respectively). LR classifier possessed the best performance in differentiating diseases. Therefore, CT‑based radiomics analysis of consolidation features may distinguish NTM pulmonary disease from TB.

Introduction

Global incidence rate of non-tuberculous mycobacteria (NTM) pulmonary disease has been increasing rapidly (1,2). In the United States, the infection rate and prevalence of NTM exceed those of tuberculosis (TB) (3-5). NTM pulmonary disease is globally prevalent. NTM is currently a key public health problem (6). The growth of NTM is slower than that of pulmonary TB, making the disease course longer. Further, the overall cure rate is low due to resistance to first-line anti-TB drugs. NTM predominantly affects the lungs (7), with patients exhibiting chronic basic diseases and low immunity being more susceptible to NTM pulmonary disease. The imaging manifestations and clinical features of NTM are similar to TB, resulting in a high rate of misdiagnosis (7). If patients with NTM pulmonary disease are treated for TB, the treatment opportunity will be delayed (8). Sputum mycobacterium culture and strain identification are currently the primary methods employed to distinguish NTM pulmonary disease from TB. However, both methods are time-consuming, arduous and require strict laboratory standards (9). Additionally, the identification of strains is dependent upon a positive sputum mycobacterium culture, which poses a diagnostic challenge. However, the employment of computed tomography (CT) offers advantages, including rapid imaging, widespread availability and high-resolution density, thereby enabling feasible discrimination between diseases (10). Despite the advantages of CT, due to the high similarity of the pathogenesis and pathological features of NTM and TB, there is no reliable image feature to distinguish them (11). Consolidation is a common and important CT feature of NTM and TB (12). Consolidation characteristics of the diseases are similar, making it difficult to distinguish with the naked eye. CT-based radiomics has exhibited potential in the diagnosis and differentiation of pulmonary diseases through high-throughput extraction and mining data features (13,14). Due to differences in pathology between these two diseases (15), the possibility of identifying the diseases is further enhanced. In the present study, the value of CT-based radiomics analysis of consolidation characteristics in differentiation of NTM pulmonary disease from TB was investigated. The present study aimed to establish an effective classifier to provide a novel simple diagnosis method for NTM and TB.

Materials and methods

Patient population and ethical approval

The present study was approved by Shandong Public Health Clinical Center (Shandong Provincial Chest Hospital) Ethics Committee and the requirement for consent for this retrospective analysis was waived (approval no. 2019XKYYEC-29). Subsequently, 89 patients with NTM pulmonary disease and 104 with TB undergoing CT imaging in the Shandong Public Health Clinical Center between January 2013 and July 2018 were retrospectively analyzed. At the same time, 27 patients with NTM pulmonary disease and 30 with TB undergoing CT imaging in the Jinan Infectious Disease Hospital (Jinan, China) were also collected for the external validation of the model. All patients with NTM pulmonary disease were diagnosed twice using sputum culture and strains were identified as the same pathogenic bacteria (16,17). All patients with TB were identified using TB diagnosis and classification standard' issued by the China National Health Service Commission on November 9th, 2017(18). The sputum smears of each patient was positive for acid-fast bacilli at least once and was identified as Mycobacterium tuberculosis complex using the colloidal gold method (19). The inclusion criteria were as follows: i) Clinical symptoms upon laboratory examination or imaging consistent with TB infection; ii) CT images of the lung window and mediastinal window exhibited consolidation and iii) treatment was effective. Exclusion criteria were as follows: i) No consolidation features in CT images; ii) CT images displayed motion artifacts, poor image quality, large differences in scanning conditions or inconsistent layer thickness; iii) clinical suspicion of mixed infection and iv) presence of non-infectious disease with similar presentation. Based on these criteria, 11 patients with NTM pulmonary disease and 23 with TB were excluded, leaving a total of 75 patients with NTM pulmonary disease, including 46 males and 29 females (mean age, 57.1±13.5 years; range 23-86 years), and 81 with TB, including 53 males and 28 females (mean age, 45.4±18.7 years; range, 17-90 years).

CT examination

All patients whose lungs had been affected underwent a plain chest scan using a Philips 64-slice spiral CT scanner (Philips Ingenuity) before treatment and quality correction standards were met prior to the CT scan. The patients were in the supine posture and underwent a scan extending from lung apices to the upper abdomen, with imaging acquisition commencing 5 cm inferior to the diaphragmatic dome at maximum inhalation. The CT scanning parameters were as follows: Diameter of the inspected detector, 64.000x0.625 mm; the rotation time was 0.5 sec; the pitch, 1.375; the tube voltage was 120 kV; the tube current was 250-400 mA, which was modulated using an automatic tube current; Field of view (FOV), 35-40 cm; matrix was 512x512 thickness of the slice, 5 mm.

Image pre-processing, segmentation and extraction of radiomics features

All images were uploaded to Radiance's Radcloud platform V7.9 mics.huiyihuiying.com (Huiying Medical Technology Co., Ltd.) for further study. A total of two radiologists (10 and 25 years of experience) with expertise in chest disease assessed and delineated the consolidations in the lung window CT images (Window Width 1500, Window Level-500). The radiologists were blinded to clinical information. The radiologists delineated the outline of the consolidation on all contiguous slices by manually sketching the region of interest (ROI), with the contour line in close proximity to the outer edge of the consolidation. The ROI entirely encompassed the consolidation. If the consolidation was close to the mediastinum, chest wall and diaphragm, the radiologists drew 1 mm along the outside of the contour of the mediastinum, chest wall and diaphragm to avoid delineating the non-consolidation. The halo caused by the surrounding exudation was not included. Finally, a senior radiologist reassessed all ROIs. If the difference was ≥5%, the senior radiologist determined the boundary of the ROI (20).

Radiomic feature extraction and selection

Using Radcloud platform, 1,409 radiomics quantitative image features were extracted from the CT images. The functions were classified into four groups. The first group (first-order statistics) comprised 18 features that quantitatively described the distribution of voxel intensity in the CT images through common and basic indicators. The second group (features based on shape and size) contained 14 three-dimensional features that reflected the shape and size of the area. The third group (texture features) consisted of grey level run-length and co-occurrence texture matrices and size zone matrix and neighboring gray tone difference and gray level dependence matrix. The fourth group (1,302 features through 14 filters) were exponential, square, square root, logarithm, gradient, local binary patterns-2D and wavelets [low-high-low (LHL), low-high-high (LHH), high-low-low (HLL), (LLH), high-low-high (HLH), high-high-high (HHH), high-high-low (HHL), and low-low-low (LLL)].

To enhance the model reliability and decrease the feature dimension, three methods were used. Variance threshold was used to remove features with variance <0.8. Secondly, the k-best method (21) was employed to remove features with P-value >0.05. To establish a more refined model, the least absolute shrinkage and selection operator (LASSO, version 1.0.2) algorithm was used to formulate a penalty function to compress select regression coefficients (22). It includes three steps: LASSO path, mean Square Error path and coefficients in LASSO model. These steps were performed 50 times in the case of random initialization. Finally, the most frequent fixed features were selected for modeling.

Statistical analysis

Based on the selected features, numerous supervised learning classifiers were used for classification (version 7.9, Huiying Medical Technology Co., Ltd.) analysis (23). Three supervised learning models were employed in the present study: K-nearest neighbor (KNN), support vector machine (SVM) and logistic regression (LR). KNN is a basic classification and regression method (24). SVM is a generalized linear classifier for binary classification of data according to supervised learning, with decision boundary being the maximum margin hyperplane for learning samples (25). LR is a generalized linear model, in which logistic function is used for regression and classification (primarily 0/1 classification). The area analysis under the receiver operating characteristic (ROC) curve (AUC) was used to illustrate the predictive performance of radiomic characteristics. When the sensitivity and specificity were the largest, the optimal cut-off value was selected. A total of 4 indicators to evaluate the AUC and prediction accuracy of the training and validation sets. It includes P [accuracy=true positive/(true positive + false positive)]; R [recall rate=true positive/(true positive + false negative)]; F1 score [1 score=P * r * 2/(P + R)]; Support: to evaluate the performance of the classifier. P<0.05 was considered to indicate a statistically significant difference.

Results

A total of 381 ROIs (203 NTM pulmonary disease and 178 TB) were manually outlined (Fig. 1A and B) in the CT images of 192 patients (Table I). Computer-generated random numbers were utilized to assign 70% of ROI to the training data cohort and 30% to the verification data cohort. Using the variance threshold method, 456 features were selected for the models. Subsequently, best K method was employed in the selection of 315 features and then the LASSO algorithm was used to select 52 optimal features (Fig. 2). Of 52 radiomics features, 34 were texture analysis, one was shapes and 17 were first-order statistical feature groups. ROC curve analysis for both the training and validation cohort for differentiating between NTM pulmonary disease and TB is illustrated in Figs. 3 and 4.

Table I

Allocation of ROIs to training, validation and external verification cohort.

Table I

Allocation of ROIs to training, validation and external verification cohort.

ROIsTotalTraining cohortValidation cohortExternal verification cohort
NTM2031243247
TB1781193029

[i] ROI, region of interest; NTM, non-tuberculous mycobacteria; TB, tuberculosis.

Three classifiers were used to analyze the characteristics of the radiomic AUC; 95% CI, sensitivity and specificity of the training cohort and verification cohort are shown in Table II. In the training cohort, AUC [95% confidence interval (CI)], sensitivity and specificity of the KNN, SVM, and LR classifiers were 0.98 (0.95-1.00), 0.93 and 0.94, 0.99 (0.97-1.00), 0.96 and 0.96 and 0.99 (0.97-1.00), 0.97 and 0.97, respectively. In the validation cohort, these were 0.90 (0.82-0.97), 0.88 and 0.83, 0.92 (0.84-1.00), 0.86 and 0.85 and 0.89 (0.81-0.96), 0.88 and 0.85, respectively. In the external verification cohort, these were 0.84 (0.66-0.82), 0.65 and 0.83, 0.90 (0.78-0.92), 0.94 and 0.77 and 0.95 (0.84-0.96), 0.94 and 0.87, respectively. The ROC curves of the three classifiers are shown in Figs. 3 and 4. All cohorts had a significant AUC value >0.84.

Table II

Receiver operating characteristic results with KNN, SVM and LR classifiers.

Table II

Receiver operating characteristic results with KNN, SVM and LR classifiers.

A, Training cohort
ClassifierAUC95% CISensitivitySpecificity
KNN0.980.95-1.000.930.94
SVM0.990.97-1.000.960.96
LR0.990.97-1.000.970.97
B, Validation cohort
ClassifierAUC95% CISensitivitySpecificity
KNN0.900.82-0.970.880.83
SVM0.920.84-1.000.860.85
LR0.890.81-0.960.880.85
C, External validation cohort
ClassifierAUC95% CISensitivitySpecificity
KNN0.840.66-0.820.650.83
SVM0.900.78-0.920.940.77
LR0.950.84-0.960.940.87

[i] AUC, area under the curve; KNN, K-nearest neighbor; SVM, support vector machine; LR, logistic regression.

In the training cohort, the precision of the three models was >0.94 and recall rate and F1 score were >0.93 (Table III). In the validation cohort, the precision of the three models was >0.83 with a recall rate and F1 score >0.86. Combining the precision, recall and F1 scores revealed that LR outperformed the other classifiers. In the external verification cohort, the precision of the three models was >0.77, the recall rate was >0.65 and F1 score was >0.69. LR classifier had the highest precision, recall and F1 score.

Table III

Precision, recall and F1 score.

Table III

Precision, recall and F1 score.

 Training cohortValidation cohortExternal verification cohort
Evaluation indicatorKNNSVMLRKNNSVMLRKNNSVMLR
Precision0.940.960.970.830.850.850.830.770.87
Recall0.930.960.970.880.860.880.650.940.94
F1 score0.930.960.970.860.860.870.690.820.88

[i] KNN, K-nearest neighbor; SVM, support vector machine; LR, logistic regression.

Discussion

NTM is a conditional pathogen caused by Mycobacteria other than M. tuberculosis complex and Mycobacterium leprae, which commonly exist in water and soil. A total of 191 species has been discovered, but only a few can cause disease (17,26-28). Individuals typically contract the disease via the environment, with water and soil being key (7,26,27). Additionally, the incidence rate of NTM pulmonary disease is increasing in United States, Germany, Canada and Taiwan (29-32). The clinical symptoms and pathology of NTM pulmonary disease are difficult to distinguish from TB and NTM is prone to natural drug resistance. The diagnosis of NTM pulmonary disease and TB is achieved via etiological detection. However, this is slow and complex, negatively impacting clinical treatment (17). In the misdiagnosis of NTM pulmonary disease as TB, the use of anti-TB treatment results in the delay of proper treatment, a prolonged course of disease, poor prognosis and possible treatment failure (33). Therefore, discovering simple and effective diagnostic methods is necessary.

Conventional CT is one of the primary detection methods for NTM pulmonary disease and pulmonary TB. However, CT manifestations of NTM pulmonary disease are complex and typically perceived as conditions such as consolidation, bronchiectasis, cavities and bronchial dissemination, which are difficult to distinguish from TB (34,35). Koh et al (36) discovered that bronchiolitis, consolidation and bronchiectasis can be perceived on CT images of NTM pulmonary disease, which often involve >5 lobes. If bronchiectasis involving the middle lobe of the right lung and the tongue segment of the upper lobe of the left lung is observed in CT images, along with cavities and nodules, NTM pulmonary disease should be considered (37). In some studies (11,15), probability of NTM consolidation is significantly lower than that of pulmonary TB. However, in other studies (12,34), the consolidation of conventional CT does not significantly differentiate NTM and TB.

Necrotizing granulomatous inflammation is the key characteristic lesion of tuberculosis, NTM pulmonary disease, Coccidiosis and cryptococcosis (37-41). NTM pulmonary disease is more prone to suppurative necrosis than TB, while pink and basophilic necrosis caused by TB are more common than NTM pulmonary disease (42). NTM pulmonary disease possesses more giant or bizarre multinucleated giant cells compared with TB (43). The aggregation of epithelial-like cells leads to proliferative granuloma in NTM and caseous necrosis is less than that in TB (15). NTM pulmonary disease may result in atypical lesions, in which tissue cell aggregation with no granuloma is seen, which is common in immunodeficient patients (44,45). Consolidation of NTM pulmonary disease is less common than TB, with low incidence, less granuloma and more suppurative necrosis. It is difficult to observe differences in the pathological features of NTM and TB in conventional CT images, resulting in decreased differential diagnosis of TB.

Radiomics has developed substantially in recent years. Radiomics involves converting medical images into high-dimensional images, extracting data features through quantitative high-throughput and the analysis of the data for decision support (46). The sensitivity and predictive value of radiomics is significant in screening of small pulmonary nodules and diagnosis, treatment and prognosis of lung cancer (47-49). Radiomics may also detect common inflammatory lesions (50,51). Deep learning has been employed (25,52,53) to distinguish NTM pulmonary disease and TB, along with use of the cavity characteristics of radiomics to distinguish the two diseases. Consolidation features are common CT features of NTM pulmonary disease and TB. CT data extracted via high-throughput radiology reflect differences in the pathological characteristics of NTM and TB, compensating for fewer differences observed by the naked eye and the loss of information.

Here, consolidations of NTM pulmonary disease and TB were noted as ROIs. High-throughput image features were computed. A total of 52 radiomics features were obtained from the ROIs, of which 34 were texture analysis, one was shape and 17 were first-order statistical feature groups. Three supervised learning classifiers (KNN, SVM and LR) were used to analyze the extracted lung consolidation features. In the training cohort, the AUC values of models were all >0.98, 95% CI was 0.95-1.00, the sensitivity was >0.93 and the specificity was >0.94. In the validation cohort, the AUC values were all >0.89, 95% CI was 0.81-0.96, the sensitivity was >0.86 and the specificity was >0.83. AUC values of the ROC curve were all significant and their sensitivity and specificity as >0.83. In the external validation set, the AUC value was similar to that of internal validation set. In the present study, the characteristics of the classifiers were analyzed using clinical indicators (accuracy, recall, F1 score and support). The precision of models was >0.77, the recall rate was >0.65 and F1 score was >0.69. Further, the LR classifier yielded the highest precision, recall, and F1 score, which were >0.86, 0.87 and 0.87, respectively. From the results, it was observed that the radiomics features derived from consolidations held potential in differentiating between NTM pulmonary disease and TB. Although in some studies, the CT imaging characteristics of NTM pulmonary disease consolidations observed through traditional clinical methods differ from those of TB (16,40), results obtained by naked eye may be subjective. However, the present radiomics characteristics of consolidations have potential to distinguish between NTM pulmonary disease and TB. Radiomics analysis of consolidation characteristics of pulmonary diseases has the advantages of objectivity, quantification, stability and non-empirical dependence. Consequently, radiomics analysis possesses value in clinical application. Using radiomics characteristics to distinguish NTM pulmonary disease from TB is a promising, non-invasive and simple method. The early diagnosis of NTM pulmonary disease may improve the quality of life of patients and treatment of the disease, especially for resource-deficient medical systems in developing countries (54,55).

There are certain limitations to the present study. First, to ensure the homogeneity of the image, 5-mm-thick images were used, which may result in loss of information. Second, the sample size was small. Multicenter studies with larger sample sizes are required to validate the present results. ROI segmentation was performed manually, which may have been affected by subjective bias. Lastly, only consolidation was investigated and other characteristics were ignored, which may have resulted in incomplete information.

In the present study, radiomics features based on CT imaging were effective in identifying NTM pulmonary disease and TB consolidation. Additionally, LR classifier outperformed the other classifiers in the recognition of consolidation of NTM pulmonary disease in patients.

Acknowledgements

Not applicable.

Funding

Funding: The present study was supported by Shandong Medical and Health Science and Technology Development Plan Project (grant no. 2019WS535).

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

QY, WZ and DY made substantial contributions to conception and design. QY, JCu and JCh made substantial contributions to acquisition of data. JCu, HK, JCh and ZD made substantial contributions to analysis and interpretation of data. QY and ZD wrote the manuscript. HK and JCu constructed figures. JCh and JCu constructed tables. All authors have read and approved the final manuscript. QY and JCu confirm the authenticity of all the raw data.

Ethics approval and consent to participate

The present study was approved by the ethics committee of Shandong Public Health Clinical Center (Shandong Provincial Chest Hospital) and the requirement for consent for this retrospective analysis was waived (approval no. 2019XKYYEC-29).

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Marshall JE, Mercaldo RA, Lipner EM and Prevots DR: Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019). BMC Infect Dis. 23(489)2023.PubMed/NCBI View Article : Google Scholar

2 

Dahl VN, Fløe A and Wejse C: Nontuberculous mycobacterial infections in a Danish region between 2011 and 2021: Evaluation of trends in diagnostic codes. Infect Dis (Lond). 55:439–443. 2023.PubMed/NCBI View Article : Google Scholar

3 

Khan K, Wang J and Marras TK: Nontuberculous mycobacterial sensitization in the United States: National trends over three decades. Am J Respir Crit Care Med. 176:306–313. 2007.PubMed/NCBI View Article : Google Scholar

4 

Khan K, Wang J, Hu W, Bierman A, Li Y and Gardam M: Tuberculosis infection in the United States: National trends over three decades. Am J Respir Crit Care Med. 177:455–460. 2008.PubMed/NCBI View Article : Google Scholar

5 

Marras TK, Chedore P, Ying AM and Jamieson F: Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax. 62:661–666. 2007.PubMed/NCBI View Article : Google Scholar

6 

Thornton CS, Mellett M, Jarand J, Barss L, Field SK and Fisher DA: The respiratory microbiome and nontuberculous mycobacteria: An emerging concern in human health. Eur Respir Rev. 30(200299)2021.PubMed/NCBI View Article : Google Scholar

7 

Chinese Medical Association Tuberculosis Branch, Editorial Board of Chinese Journal of Tuberculosis and Respiratory Medicine. Expert consensus on diagnosis and treatment of nontuberculous mycobacterial disease. Chin J Tubercul Respir Dis. 35:572–580. 2012.

8 

Gopalaswamy R, Shanmugam S, Mondal R and Subbian S: Of tuberculosis and non-tuberculous mycobacterial infections-a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci. 27(74)2020.PubMed/NCBI View Article : Google Scholar

9 

Cao P, Liu F and Li H: Clinical analysis of 58 cases of non-tuberculous mycobacteria. Chongqing Med J. 43:854–856. 2014.(In Chinese).

10 

Chu HQ, Li B, Zhao L, Huang DD, Zhang ZM, Xu JF, Zhang JB, Gui T, Xu LY and Sun XW: Chest imaging comparison between non-tuberculous and tuberculosis mycobacteria in sputum acid fast bacilli smear-positive patients. Eur Rev Med Pharmacol Sci. 19:2429–2439. 2015.PubMed/NCBI View Article : Google Scholar

11 

You Z and Zhu X: CT findings of pulmonary nontuberculous mycobacterial disease. Chin J Clin Med Imaging. 16:141–143. 2005.

12 

Dai J, Shi J and Liang L: Comparison of CT findings between non tuberculous mycobacterial lung disease and secondary pulmonary tuberculosis. Chin J Tubercul. 36:706–709. 2014.

13 

Ma J, Zhou Z, Ren Y, Xiong J, Fu L, Wang Q and Zhao J: Computerized detection of lung nodules through radiomics. Med Phys. 44:4148–4158. 2017.PubMed/NCBI View Article : Google Scholar

14 

Coroller TP, Agrawal V, Huynh E, Narayan V, Lee SW, Mak RH and Aerts HJWL: Radiomic-based pathological response prediction from primary tumors and lymph nodes in NSCLC. J Thorac Oncol. 12:467–476. 2017.PubMed/NCBI View Article : Google Scholar

15 

Wittram C and Weisbrod GL: Mycobacterium avium complex lung disease in immunocompetent patients: Radiography-CT correlation. Br J Radiol. 75:340–344. 2002.PubMed/NCBI View Article : Google Scholar

16 

Guo H: To explore the clinical value of CT in the diagnosis and clinicopathological classification of peripheral small lung cancer. China Contin Med Educ. 8(48)2016.(In Chinese).

17 

Daley CL, Iaccarino JM, Lange CG, Cambau E, Wallace RJ Jr, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, et al: Treatment of nontuberculous mycobacterial pulmonary disease: An official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 56(2000535)2020.PubMed/NCBI View Article : Google Scholar

18 

Liu E, Zhou L and Wang L: Comprehensively interpret the standards of 'ws 196-2017 tuberculosis classification. Chin J Tubercul Prev. 40(5)2018.(In Chinese).

19 

Wang Y, Lu B, Liu J, Xiao T, Wan K and Guan C: A multicenter clinical evaluation of Mycobacterium tuberculosis IgG/IgM antibody detection using the colloidal gold method. Eur J Clin Microbiol Infect Dis. 33:1989–1994. 2014.PubMed/NCBI View Article : Google Scholar

20 

Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A and Aerts HJ: Radiomics: Extracting more information from medical images using advanced feature analysis. Eur J Cancer. 48:441–446. 2012.PubMed/NCBI View Article : Google Scholar

21 

Akman DV, Malekipirbazari M, Yenice ZD, Yeo A, Adhikari N, Wong YK, Abbasi B and Gumus AT: K-best feature selection and ranking via stochastic approximation. Expert Syst Appl. 213(118864)2023.

22 

Choi H, Song E, Hwang SS and Lee W: A modified generalized lasso algorithm to detect local spatial clusters for count data. AStA Adv Stat Anal. 102:537–563. 2018.

23 

Sun H, Zhou P, Chen G, Dai Z, Song P and Yao J: Radiomics nomogram for the prediction of Ki-67 index in advanced non-small cell lung cancer based on dual-phase enhanced computed tomography. J Cancer Res Clin Oncol. 149:9301–9315. 2023.PubMed/NCBI View Article : Google Scholar

24 

Hapsari DP, Utoyo I and Purnami SW: Support vector machine optimization with fractional gradient descent for data classification. J Appl Sci Manag Eng Technol. 2:1–6. 2021.

25 

Zhou Z: Machine learning. Tsinghua University Press, pp121-139, 298-300, 2016.

26 

Wang L, Ding W, Mo Y, Shi D, Zhang S, Zhong L, Wang K, Wang J, Huang C, Zhang S, et al: Distinguishing nontuberculous mycobacteria from Mycobacterium tuberculosis lung disease from CT images using a deep learning framework. Eur J Nucl Med Mol Imaging. 8:4293–4306. 2021.PubMed/NCBI View Article : Google Scholar

27 

Biondi G, Sotgiu G, Dore S, Molicotti P, Ruggeri M, Aliberti S and Satta R: Beyond pulmonary nontuberculous mycobacteria disease: Do extra-pulmonary forms represent an emerging clinical and public health threat? ERJ Open Res. 3:00091–2017. 2017.PubMed/NCBI View Article : Google Scholar

28 

Aboagye SY, Danso E, Ampah KA, Nakobu Z, Asare P, Otchere ID, Röltgen K, Yirenya-Tawiah D and Yeboah-Manu D: Isolation of nontuberculous mycobacteria from the environment of ghanian communities where buruli ulcer is endemic. Appl Environ Microbiol. 82:4320–4329. 2016.PubMed/NCBI View Article : Google Scholar

29 

Chen CY, Chen HY, Chou CH, Huang CT, Lai CC and Hsueh PR: Pulmonary infection caused by nontuberculous mycobacteria in a medical center in Taiwan, 2005-2008. Diagn Microbiol Infect Dis. 72:47–51. 2012.PubMed/NCBI View Article : Google Scholar

30 

Vinnard C, Longworth S, Mezochow A, Patrawalla A, Kreiswirth BN and Hamilton K: Deaths related to nontuberculous mycobacterial infections in the United States, 1999-2014. Ann Am Thorac Soc. 13:1951–1955. 2016.PubMed/NCBI View Article : Google Scholar

31 

Ringshausen FC, Wagner D, de Roux A, Diel R, Hohmann D, Hickstein L, Welte T and Rademacher J: Prevalence of nontuberculous mycobacterial pulmonary disease, Germany, 2009-2014. Emerg Infect Dis. 22:1102–1105. 2016.PubMed/NCBI View Article : Google Scholar

32 

Marras TK, Campitelli MA, Lu H, Chung H, Brode SK, Marchand-Austin A, Winthrop KL, Gershon AS, Kwong JC and Jamieson FB: Pulmonary nontuberculous mycobacteria-associated deaths, Ontario, Canada, 2001-2013. Emerg Infect Dis. 23:468–476. 2017.PubMed/NCBI View Article : Google Scholar

33 

Jing H, Wang H, Wang Y, Deng Y, Li X, Liu Z, Graviss EA and Ma X: Prevalence of nontuberculous mycobacteria infection, China, 2004-2009. Emerg Infect Dis. 18:527–528. 2012.PubMed/NCBI View Article : Google Scholar

34 

Eisenberg I, Yasin A, Fuks L, Stein N, Saliba W, Kramer MR, Adir Y and Shteinberg M: Radiologic characteristics of non-tuberculous mycobacteria infection in patients with bronchiectasis. Lung. 198:715–722. 2020.PubMed/NCBI View Article : Google Scholar

35 

Kwak N, Lee JH, Kim HJ, Kim SA and Yim JJ: New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: Tracking the clinical and radiographic changes. BMC Pulm Med. 20(293)2020.PubMed/NCBI View Article : Google Scholar

36 

Koh WJ, Lee KS, Kwon OJ, Jeong YJ, Kwak SH and Kim TS: Bilateral bronchiectasis and bronchiolitis at thin-section CT: Diagnostic implications in nontuberculous mycobacterial pulmonary infection. Radiology. 235:282–288. 2005.PubMed/NCBI View Article : Google Scholar

37 

Aksamit TR, Philley JV and Griffith DE: Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials. Respir Med. 108:417–425. 2014.PubMed/NCBI View Article : Google Scholar

38 

Marchevsky A, Damsker B, Gribetz A, Tepper S and Geller SA: The spectrum of pathology of nontuberculous mycobacterial infections in open-lung biopsy specimens. Am J Clin Pathol. 78:695–700. 1982.PubMed/NCBI View Article : Google Scholar

39 

Goodwin RA Jr and Snell JD Jr: The enlarging histoplasmoma. Concept of a tumor-like phenomenon encompassing the tuberculoma and coccidioidoma. Am Rev Respir Dis. 100:1–12. 1969.PubMed/NCBI View Article : Google Scholar

40 

Mukhopadhyay S and Gal AA: Granulomatous lung disease: An approach to the differential diagnosis. Arch Pathol Lab Med. 134:667–690. 2010.PubMed/NCBI View Article : Google Scholar

41 

Mukhopadhyay S: Role of histology in the diagnosis of infectious causes of granulomatous lung disease. Curr Opin Pulm Med. 17:189–196. 2011.PubMed/NCBI View Article : Google Scholar

42 

Mu J, Liu Z and Zhang C: Pathological characteristics of nontuberculous Mycobacterium tuberculosis and the value of molecular pathology in its diagnosis. Chin J Pathol. 49:562–567. 2020.PubMed/NCBI View Article : Google Scholar

43 

O'Leary S, O'Sullivan MP and Keane J: IL-10 blocks phagosome maturation in Mycobacterium tuberculosis-infected human macrophages. Am J Respir Cell Mol Biol. 45:172–180. 2011.PubMed/NCBI View Article : Google Scholar

44 

Jannotta FS and Sidawy MK: The recognition of mycobacterial infections by intraoperative cytology in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 113:1120–1123. 1989.PubMed/NCBI

45 

Marinelli DL, Albelda SM, Williams TM, Kern JA, Iozzo RV and Miller WT: Nontuberculous mycobacterial infection in AIDS: Clinical, pathologic, and radiographic features. Radiology. 160:77–82. 1986.PubMed/NCBI View Article : Google Scholar

46 

de la Pinta C: Radiomics in pancreatic cancer for oncologist: Present and future. Hepatobiliary Pancreat Dis Int. 21:356–361. 2022.PubMed/NCBI View Article : Google Scholar

47 

Gulshan V, Peng L, Coram M, Stumpe MC, Wu D, Narayanaswamy A, Venugopalan S, Widner K, Madams T, Cuadros J, et al: Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA. 316:2402–2410. 2016.PubMed/NCBI View Article : Google Scholar

48 

Chae HD, Park CM, Park SJ, Lee SM, Kim KG and Goo JM: Computerized texture analysis of persistent part-solid ground-glass nodules: Differentiation of preinvasive lesions from invasive pulmonary adenocarcinomas. Radiology. 273:285–293. 2014.PubMed/NCBI View Article : Google Scholar

49 

Liu Y, Kim J, Balagurunathan Y, Li Q, Garcia AL, Stringfield O, Ye Z and Gillies RJ: Radiomic features are associated with EGFR mutation status in lung adenocarcinomas. Clin Lung Cancer. 17:441–448.e6. 2016.PubMed/NCBI View Article : Google Scholar

50 

Zhang T, Yuan M, Zhong Y, Zhang YD, Li H and Wu JF: Differentiation of focal organising pneumonia and peripheral adenocarcinoma in solid lung lesions using thin-section CT-based radiomics. Clin Radiol. 74:78.e23–78.e30. 2019.PubMed/NCBI View Article : Google Scholar

51 

Yanling W, Duo G, Zuojun G, Zhongqiang S, Yankai W, Shan L and Hongying C: Radiomics nomogram analyses for differentiating pneumonia and acute paraquat lung injury. Sci Rep. 9(15029)2019.PubMed/NCBI View Article : Google Scholar

52 

Yan Q, Wang W, Zhao W, Zuo L, Wang D, Chai X and Cui J: Differentiating nontuberculous mycobacterium pulmonary disease from pulmonary tuberculosis through the analysis of the cavity features in CT images using radiomics. BMC Pulm Med. 22(4)2022.PubMed/NCBI View Article : Google Scholar

53 

Xing Z, Ding W, Zhang S, Zhong L, Wang L, Wang J, Wang K, Xie Y, Zhao X, Li N and Ye Z: Machine learning-based differentiation of nontuberculous mycobacteria lung disease and pulmonary tuberculosis using CT images. Biomed Res Int. 2020(6287545)2020.PubMed/NCBI View Article : Google Scholar

54 

Tan Y, Su B, Shu W, Cai X, Kuang S, Kuang H, Liu J and Pang Y: Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016. BMC Pulm Med. 18(168)2018.PubMed/NCBI View Article : Google Scholar

55 

Maurya AK, Nag VL, Kant S, Kushwaha RAS, Kumar M, Singh AK and Dhole TN: Prevalence of nontuberculous mycobacteria among extrapulmonary tuberculosis cases in tertiary care centers in Northern India. Biomed Res Int. 2015(465403)2015.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

March-2024
Volume 27 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yan Q, Zhao W, Kong H, Chi J, Dai Z, Yu D and Cui J: CT‑based radiomics analysis of consolidation characteristics in differentiating pulmonary disease of non‑tuberculous mycobacterium from pulmonary tuberculosis. Exp Ther Med 27: 112, 2024.
APA
Yan, Q., Zhao, W., Kong, H., Chi, J., Dai, Z., Yu, D., & Cui, J. (2024). CT‑based radiomics analysis of consolidation characteristics in differentiating pulmonary disease of non‑tuberculous mycobacterium from pulmonary tuberculosis. Experimental and Therapeutic Medicine, 27, 112. https://doi.org/10.3892/etm.2024.12400
MLA
Yan, Q., Zhao, W., Kong, H., Chi, J., Dai, Z., Yu, D., Cui, J."CT‑based radiomics analysis of consolidation characteristics in differentiating pulmonary disease of non‑tuberculous mycobacterium from pulmonary tuberculosis". Experimental and Therapeutic Medicine 27.3 (2024): 112.
Chicago
Yan, Q., Zhao, W., Kong, H., Chi, J., Dai, Z., Yu, D., Cui, J."CT‑based radiomics analysis of consolidation characteristics in differentiating pulmonary disease of non‑tuberculous mycobacterium from pulmonary tuberculosis". Experimental and Therapeutic Medicine 27, no. 3 (2024): 112. https://doi.org/10.3892/etm.2024.12400